1. X Wang #, GN Shi #, R Wei, M Li, QY Zhang, TT Zhang*, C-F Chen*, H-Y Hu*. Fine-tuning of stable organic free-radical photosensitizers for photodynamic immunotherapy. Chem Sci, 2024, 15(17):6421-6431.
2. S Shao #, CJ Chen #, GN Shi, Y Zhou, YZ Wei, L Wu, L Sun*, TT Zhang*. JAK inhibition ameliorated EAE by blocking GM-CSF-driven inflammatory signature of monocytes. Acta Pharm Sin B, 2023, 13(10):4185-4201.
3. GN Shi, Y Zhou, WS Liu, CJ Chen, YZ Wei, XL Yan, L Wu, WW Wang*, L Sun*, TT Zhang*. Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A/2B receptors in tolerogenic dendritic cells. Acta Pharm Sin B, 2023, 13(6):2778-2794
4. CJ Chen, Y Yin, GN Shi, Y Zhou, S Shao, YZ Wei, L Wu, DY Zhang*, L Sun*, TT Zhang*. A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokines related JAK-STAT signal. Sci Adv. 2022, 8(33):eabo4363.
5. JF Zhang, XQ Lei, YZ Wei, H Liu, QL Guo*, TT Zhang*, JG Shi*. Two unique C21-diterpenoid alkaloids from Aconitum carmichaelii. Chin Chem Lett., 2022, 33(12):5047-50.
6. S Shao, CJ Chen, GN Shi, Y Zhou, YZ Wei, NY Fan, Y Yang, L Wu, TT Zhang*. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacol Ther. 2021, 227: 107880.
7. S Shao#, CB Xu#, CJ Chen, GN Shi, QL Guo, Y Zhou, YZ Wei, L Wu, JG Shi*, TT Zhang*. Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice. J Neuroinflammation. 2021, 18:142.
8. JK Liu#, CJ Chen#, DM Wang, J Zhang*, TT Zhang*. Emerging small-molecule inhibitors of the Bruton’s Tyrosine Kinase (BTK): current development. Eur J Med Chem. 2021, 217: 113329.
9. QL Guo, H Xia, YZ Wu, S Shao, CB Xu, TT Zhang*, JG Shi*. Structure, property, biogenesis, and activity of diterpenoid alkaloids containing a sulfonic acid group from Aconitum carmichaelii. Acta Pharm Sin B, 2020, 10(10):1954-65.
10. S Shao, H Xia, M Hu, CJ Chen, JM Fu, GN Shi, QL Guo, Y Zhou, WJ Wang, JG Shi*, TT Zhang*. Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway mediated microglial dynorphin A expression. J Neuroinflammation. 2020, 17: 13.